Hydroxyzine Hydrochloride Tablets , USP are available as follows : 10 mg tablets : round , film coated white tablets .
Debossed H on one side and 500 on the reverse side .
They are available as follows : Bottles of 100 : NDC 23155 - 500 - 01 Bottles of 500 : NDC 23155 - 500 - 05 Bottles of 1000 : NDC 23155 - 500 - 10 25 mg tablets : round , film coated white tablets .
Debossed H over 501 on one side and plain on the reverse side .
They are available as follows : Bottles of 100 : NDC 23155 - 501 - 01 Bottles of 500 : NDC 23155 - 501 - 05 Bottles of 1000 : NDC 23155 - 501 - 10 50 mg tablets : round , film coated white tablets .
Debossed H over 502 on one side and plain on the reverse side .
They are available as follows : Bottles of 100 : NDC 23155 - 502 - 01 Bottles of 500 : NDC 23155 - 502 - 05 Bottles of 1000 : NDC 23155 - 502 - 10 Dispense in a tight container as defined in the USP , with a child - resistant closure ( as required ) .
Store at 20 ° to 25 ° C ( 68 ° to 77 ° F ) [ See USP Controlled Room Temperature ] .
KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN .
Distributed by : Avet Pharmaceuticals Inc .
East Brunswick , NJ 08816 1 . 866 . 901 .
DRUG ( 3784 ) logo 51U000000193US07 Rev . 10 / 2019 For symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested : adults , 50 to 100 mg q . i . d . ; children under 6 years , 50 mg daily in divided doses ; children over 6 years , 50 to 100 mg daily in divided doses .
For use in the management of pruritus due to allergic conditions such as chronic urticaria and atopic and contact dermatoses and in histamine - mediated pruritus : adults , 25 mg t . i . d . or q . i . d . ; children under 6 years , 50 mg daily in divided doses ; children over 6 years , 50 to 100 mg daily in divided doses .
As a sedative when used as a premedication and following general anesthesia : 50 to 100 mg for adults and 0 . 6 mg / kg of body weight in children .
When treatment is initiated by the intramuscular route of administration , subsequent doses may be administered orally .
As with all potent medication , the dosage should be adjusted according to the patient ' s response to therapy .
The most common manifestation of hydroxyzine overdosage is hypersedation .
Other reported signs and symptoms were convulsions , stupor , nausea and vomiting .
As in the management of overdosage with any drug , it should be borne in mind that multiple agents may have been taken .
If vomiting has not occurred spontaneously , it should be induced .
Immediate gastric lavage is also recommended .
General supportive care , including frequent monitoring of the vital signs and close observation of the patient , is indicated .
Hypotension , though unlikely , may be controlled with intravenous fluids and levarterenol or metaraminol .
Do not use epinephrine as hydroxyzine counteracts its pressor action .
Hydroxyzine overdose may cause QT prolongation and Torsade de Pointes .
ECG monitoring is recommended in cases of hydroxyzine overdose .
There is no specific antidote .
It is doubtful that hemodialysis would be of any value in the treatment of overdosage with hydroxyzine .
However , if other agents such as barbiturates have been ingested concomitantly , hemodialysis may be indicated .
There is no practical method to quantitate hydroxyzine in body fluids or tissue after its ingestion or administration .
For symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested .
Useful in the management of pruritus due to allergic conditions such as chronic urticaria and atopic and contact dermatoses and in histamine - mediated pruritus .
As a sedative when used as a premedication and following general anesthesia , hydroxyzine may potentiate meperidine and barbiturates , so their use in pre - anesthetic adjunctive therapy should be modified on an individual basis .
Atropine and other belladonna alkaloids are not affected by the drug .
Hydroxyzine is not known to interfere with the action of digitalis in any way and it may be used concurrently with this agent .
The effectiveness of hydroxyzine as an antianxiety agent for long term use , that is more than 4 months , has not been assessed by systematic clinical studies .
The physician should reassess periodically the usefulness of the drug for the individual patient .
Hydroxyzine hydrochloride is unrelated chemically to the phenothiazines , reserpine , meprobamate or the benzodiazepines .
Hydroxyzine is not a cortical depressant , but its action may be due to a suppression of activity in certain key regions of the subcortical area of the central nervous system .
Primary skeletal muscle relaxation has been demonstrated experimentally .
Bronchodilator activity , and antihistaminic and analgesic effects have been demonstrated experimentally and confirmed clinically .
An antiemetic effect , both by the apomorphine test and the veriloid test , has been demonstrated .
Pharmacological and clinical studies indicate that hydroxyzine in therapeutic dosage does not increase gastric secretion or acidity and in most cases has mild antisecretory activity .
Hydroxyzine is rapidly absorbed from the gastrointestinal tract and hydroxyzine ' s clinical effects are usually noted within 15 to 30 minutes after oral administration .
Hydroxyzine hydrochloride , USP has the chemical name of ( ± ) - 2 - [ 2 - [ 4 - ( p - Chloro - α - phenylbenzyl ) - 1 - piperazinyl ] ethoxy ] ethanol dihydrochloride .
stucture Molecular Formula : C21H27ClN2O2 · 2 HCl Molecular Weight : 447 . 83 Hydroxyzine hydrochloride , USP occurs as a white , odorless powder which is very soluble in water .
Each tablet for oral administration contains 10 mg , 25 mg , or 50 mg hydroxyzine hydrochloride , USP .
Inactive ingredients include anhydrous lactose , colloidal silicon dioxide , crospovidone , hypromellose , magnesium stearate , microcrystalline cellulose , polyethylene glycol , polysorbate and titanium dioxide .
[ MULTIMEDIA ] [ MULTIMEDIA ]
